KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

NovoCure (NVCR) Receivables - Net (2016 - 2025)

NovoCure's Receivables - Net history spans 12 years, with the latest figure at $58.7 million for Q4 2025.

  • For Q4 2025, Receivables - Net rose 67.32% year-over-year to $58.7 million; the TTM value through Dec 2025 reached $58.7 million, up 67.32%, while the annual FY2025 figure was $58.7 million, 67.32% up from the prior year.
  • Receivables - Net for Q4 2025 was $58.7 million at NovoCure, up from $39.5 million in the prior quarter.
  • Across five years, Receivables - Net topped out at $97.6 million in Q2 2022 and bottomed at $17.0 million in Q4 2021.
  • The 5-year median for Receivables - Net is $49.1 million (2025), against an average of $51.8 million.
  • The largest annual shift saw Receivables - Net crashed 82.39% in 2021 before it soared 443.65% in 2022.
  • A 5-year view of Receivables - Net shows it stood at $17.0 million in 2021, then surged by 52.48% to $26.0 million in 2022, then decreased by 12.64% to $22.7 million in 2023, then skyrocketed by 54.62% to $35.1 million in 2024, then surged by 67.32% to $58.7 million in 2025.
  • Per Business Quant, the three most recent readings for NVCR's Receivables - Net are $58.7 million (Q4 2025), $39.5 million (Q3 2025), and $39.1 million (Q2 2025).